FDA & DEA Regulation of Opioid Drugs & Crisis 2022 - McDermott

FDA and DEA Regulation of Opioid Drugs and the Opioid Crisis 2022

Overview


Brian Malkin joins the DC Bar for their event, “FDA and DEA Regulation of Opioid Drugs and the Opioid Crisis 2022.” Brian and panel will cover, the regulation of opioid drugs and the legal issues involved in combating this crisis in the United States. The panel will also discuss how the US Drug Enforcement Administration (DEA) schedules opioid drugs and develops annual quotas and prevents diversion, and how pain and substance abuse treatment doctors from the American Medical Association’s perspective view these important regulatory issues and interact with the regulators at the FDA and DEA.

Learn more and register here.

Dig Deeper

London, United Kingdom / McDermott Event / September 19, 2024

HPE Europe 2024

Boston, MA / Speaking Engagements / May 8-9, 2024

LSPN North America – Spring 2024

San Francisco, CA / McDermott Event / May 1, 2024

Life Sciences Boot Camp for In-House Counsel 2024 | San Francisco

Dallas, TX / McDermott Event / April 4, 2024

BIO BREAK: Dallas' Monthly Life Sciences Happy Hour